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DNA encoding Ricinus comtunis agglutinin A chain was ligated into the E. co/i expression VCCIO~ pDS 513. Induced E. coii 71.18 cells which ad 
been transformed with this plasmid express Ricitrus cottrtmmis agglutinin A chain in M soluble and biologically active form. Recombinant Riclnur 
cmtmnis agglutinin A chain had ribosomal RNA N.glycosidase activity and was approximately IO-fold less active than ricin A chain in a cell-free 
protein synthesis inhibition assay. 
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1. INTRODUCTION 
Castor beans (Ricinrrs conm~is seeds) contain two 
closely related types of lectins, ricin and Ricinrrs cotn- 
tnutG. agglutinin (RCA) [1,2]. Ricin is a heterodimeric 
protein consisting of a catalytically active polypcptide 
(the A chain) covalently linked via a single disulphide 
bond to a galactose-specific lectin (the B chain) [3]. 
RC.4 is a tetramer in which two ricin-like hcterodimers 
are held together by non-covalent forces. The corre- 
sponding polypeptides of ricin and RCA share extensive 
sequence homology. The A chains, which contain 267 
amino acid residues, differ in only 18 residues, and the 
262 residue-long l3 chains differ at 41 position [4]. 
In spite of this extensive sequence homology, ricin 
and RCA differ markedly in their biological properties. 
RCA is 60-Z times more potent than ricin in the ag- 
glutination of erythrocytcs [2]. However, RCA is 2000- 
fold less toxic than ricin when injected intraperitoneally 
into mice [5]. After entering the cytosol of target cells, 
ricin A chain specifically depurinates a conserved 
surface loop present in 28 S ribosomal RNA [6,7]. Ri- 
bosomes containing depurinated 28 S RNA can no 
longer carry out protein synthesis, which leads to cell 
death. 
The apparent difference in cytotoxicity between ricin 
and RCA does not appear to simply reflec.t a difference 
in protein synthesis inhibition by the corresponding A
chains [2]. It appears that differences in quaternary 
structure also influence the ease with which the A chain 
enters target cells in vivo. In an attempt o confirm this, 
we have produced soluble, biologically active RCA A 
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chain in E. coil. The abilit!: of recombinant RCA A 
chain to inhibit protein sythesis by mammalian ri- 
bosomes in vitro and its cytotoxicity to cultured ceils 
after reassociation with purified ricin B chain has been 
determined and compared to recombinant ricin A 
chain. 
2. MATERIALS AND METHODS 
2. I. Materids 
Restriction endonucleases, T4 l&se, [“S] methionine, [“C] leucine 
and biotinylated protein A/strcptavidin-horseradish peroxidase were 
obtained from Amersham (Bucks, England). Isopropyl&D-thioglnc- 
topyranoside (IPTG), ampicillin. plenylmethylsulphonyl Ruoridc 
(PMSFj and lysozymc (grade I) were obtained from Sigma (Dorset. 
England). Polybuffer exchanger PBE94 and polybuffer 74 were from 
Pharmacia (Uppsala, Sweden). Vector pDS5/3 was kindly provided by 
Dr. B. Dobberstein (EMBL, Heidelberg, Germany). 
2.2. General nrerhods 
Plasmid DNAs were prepared byIhe alkaline lysis method [8] and 
purified by centrifugation in cesuim chlorldc-ethidium bromide. 
Restriction enqmc digests and ligations were carried out as re. 
commended by the suppliers. 
2.3. Cotrsrrucriott of pRCA/A 
An RCA-encoding plasmid, pRCLS2, has been described earlier [4]. 
The 3’ end of a ricin A chainsncoding cDNA was substituted into this 
clone by taking a 260 bp Bg!ll-EcoRI kqment brorn a plasmid con- 
taining ricin A chain DNA followed by a stop codon. and ligating with 
the large &III-EcoRI fragment pRCL52. A Ff~~dIil-EcoRI fragment 
containing the complete RCA A chain coding sequence with the stop 
codon derived from pUC8RA. was subcloned imo M 15 and an Xlrol 
site created by site-directed mutagenesis at IS in the RCA pru- 
sequence r gion. An Ylrol-SUJ kqmcnt was subsequently retrieved. 
passaged through pUCl8 and a &IrrlHI fragment cloned into pDS5/3 
exactly as described for the construction of a ricln A chainencoding 
expression plasmid [9:$ 
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strain 71.18 by calcium chloride-mediated transformation, 500 ml 
cultures were grown at 30°C in the presence of ampicillin (50 pg/ml) 
and IPTG (2 mM) to an AJw of 0.8. E. colt’ cells were harvested by 
centrifugation and resuspended in 2 ml of 0.15 M NaCI. IO mM Na 
phosphate, pH 7.4. containing I mM PMSF. Lysozyme was added IO 
2 mdml and, afier standing for IO min on ice, the cells were lysed on 
ice by sonication using three 20 s bursts from an MSE ultrasonic 
disintegrator (amplitide 24). Lysates were cleared by centrifugation at
12.000 x 6 for 30 min at 4°C. 
2.5. Isoluriut~ of wcotr~btiwnr RCA A cltuin 
Cell-free lysate supernatants were dialysed agains 25 mM imi- 
datolelHC1, pH 7.4, and passed over a chromalofocusing column of 
polybuffer exchanger PBE94 (1~6 x 30 cm) equilibrated in the same 
buffer. A pH gradient (pH 7.ti.O) was developed by passing through 
the column 600 ml of polybull’er 74 (diluted I:10 in HJI). Fractions 
having a pH of 5.9 (the pl of RCA A chain) were analysed by SDS- 
polyacrylamide gel electrophoresis [IO] and Western blotting [l I]. 
Biots were probed with rabbit antibodies raised against ricin A chain 
purified from Riches seeds and developed using the biotinylated pro- 
tein A/streptavidin-peroxidase system (according to the manufac- 
turer’s instructions). 
2.6. Acrivity of rccotttbitrattr RCA A cltuitt in t~ficukw,w /ysurcs 
The biological activity of recombinant RCA A chain was deter- 
mined by its ability to inhibit [lJC]leucinc incorporation into protein 
in a rabbit r&ulocyte lysate [I 21. Various concentrations of recom- 
binant RCA A chain or recombinant ricin A chain [9] (OS-50 @ml) 
were assayed for inhibition with respect o controls over a 5 min 
translation period at 28°C. Each concentration was assayed in tripli- 
cate, 
Reaction mixtures containing rabbit reticulocyte ribosomes (30~6) 
were incubated with recombinant toxins in 25 mM KCI, 5 mM MgCIz, 
25 mM Tris-HCI, pH 7.6, at 30°C for I h. C.nrr~r~-~l rexlions lacking 
toxin were similarly incubated. RNA was extracted [13] and dissolved 
in sterile distilled water at 3pg/int. Aniline treatment ol’the rRNA and 
elcctrophoresis in agarose/formamidc gels were carried out as de. 
scribed previously [14]. 
Vcro cells (2 x IO’) in 0.1 ml Dulbecco’s modified Eagles medium 
(DMEM) containing 5% foelal calf serum supplemented with O,l% 
glutamine were added to the wells of 96-well microtitre plates and 
incubated at 37°C in 5% CO= Toxin or control solutions (25~1) were 
added to thecells which had been washed in phosphate-buffered saline 
(PBS). After 20 h, each well was pulsed for 2 h with I #Ii [?$]mc- 
thionine in 50~11 PBS at 37°C. After washing thecells in PBS followed 
by 5% TCA they were lysed in OS M NaOH and the precipitate was 
collected and countccl. 
3. RESULTS AND DISCUSSION 
The RCA A chain construct used here was generated 
by fusing DNA encoding the bulk of the RCA A chain 
(except for a small region encoding the carboxyl 
terminus), with DNA encoding the missing carboxyter- 
minal region but which had been taken from ricin A 
chain cDNA. This strategy was used to incorporate a 
stop codnn which had pretiorlsly been engineered Into 
the ricin A chain DNA. The resulting gene encoded a 
mutant form of RCA A chain which differed from the 
wild type at a single amino acid residue; the ricin A 
chain-derived DNA encodes erine at residue 241 rather 
than the asparagine normally present in RCA A chain. 
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Fig. I. Expression of RCA A chain. Cytoplasmic supernatants from 
E. rofi cells transformed with the expression plasmid were subjected 
to chromatofocusing and the pli 5.9 fraction (lane I) and pi-l 7.0 
fraction (lane 3) were analysed by SDS-PAGE and silver stained (A) 
or blotted onto nitrocellulose and probed with anti-ricin A chain 
amihodirs (8). Lane 2 conlained purified recombinant ricin A chain. 
The strategy used to modify the 5’ en::i of the RCA A 
chain coding sequence was exactly the same as that 
described previously in the case of ricirl A chain [9]. A 
BarlrHI fragment containing the RCA A. chain sequence 
was cloned into the expression site of the vector pDS5/3 
[15]. This vector contain the strong ccJiphsge T5 pro- 
moter P,,, fused to the E. cob kc operator, with a 
ribosome binding site and initiation co&ion immediately 
upstream from the unique BunlHI expression site. 
Downstream are sequences for efficient transcription 
termination. The expression plasmid generated irects 
the synthesis of a ft!sion protein in which the recom- 
binant RCA A chain sequence (267 amino acid residues) 
is preceded by a 10 residue N-terminal extension, of 
which the initiator methionine is derived from the 
vector, 5 residues are from the pUC18 polylinker and 
4 residues are from the RCA A chain N-terminal eader 
[9]. The recombinant fusion protein was calculated to 
have a molecular mass of about 30 kDa. 
E, cd’ 71,18 cells were t ansformed with vector alone 
or wiih a recombinant plasmid containing the RCA .A 
chain insert either in the correct orientation for expres- 
sion or in the reverse orientation. Transformants were 
grown at 30°C in L broth supplemented with ampicillin 
and the inducer IP’W. After homogenization, dialysed 
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Fig, 2. Depurination of rabbit reliculocyte ribosomes. Ribosomes 
were incubated with test prokin, rRNA was extracted and 3 pg ali- 
quots were treated with aniline, These samples together with non- 
aniline trealed controls were fraclionated on a 2.2% ugarosc-for- 
mamide gel and lhe bands were visualized by ethidium bromide stain- 
ing, Lanes I and 2, untreated control ribosomcs: lanes 3 and 1, rim 
boscmc incubated with 100 ng native ricin A chain; lanes 5 2nd 6, 
ribosomcs incubated with LOO ng of recombintint ricin A chain: lanes 
7 and 8. ribosomes incubated wiih 10s ng recombinant RCA A chain. 
+, indicates aniline treatment; -, indicates no aniline treatment, 
cell-free supernatants were passed down a chromato- 
focusing column which was then treated with a pH 
gradient (pH 7.4-4.0). Collected fractions having a pH 
of-S.9 (the pl of RCA A chain) were analysed by SDS/ 
polyacrylamide gel electrophoresis (Fig. IA, lane 1). 
This fraction contained a major band of molecular mass 
‘30 kDa whose mobility on the gel was identical to that 
of purified recombinant ricin A (Fig, IA, lane 2) and 
which was not present in a fraction of higher pH (Fig. 
1 A, lane 3). The 30 kDa band was identified as RCA 
A chain since, in addition to having the correct PI, it (i) 
reacted strongly with rabbit antibodies raised against 
ricin A chain (Fig. 1 B, lane I), and (ii) it was not present 
in supernatants from cells transformed with vector 
alone or with vector containing the insert in the reverse 
orientation (data not shown). 
Recombinant RCA A chain produced in E. coli was 
catalytically active and capable of specifically depu- 
rinating 28 S rRNA. Depurinated 28 S rRNA is sus- 
ceptible to aminecatalyseti hydrolysis of the sugar- 
phosphate backbone at the depurination site, releasing 
a small fragment of around 390 nucleotides from the 3’ 
end of the rRNA. This fragment is diagnostic for ri- 
bosome-inactivating r+glycosidases and is readily ob- 
served following agarose/formamide g l electrophore- 
L I I I I I I 
0 10 20 30 40 50 
[A chain] (ng/ml) 
Fig, 3. Biological activity of recombinant A chains. Various con- 
centrations of ricin A chain (0) or RCA A chain (0) were tested for 
their ability to inhibit cell-free protein synthesis in the rabbit reticu- 
locyte assay. 
sis. Hydrolysis of recombinant RCA A chain-treated 
rabbit reticulocyte ribosomes produced the diagnostic 
fragment (Fig. 2, lane 4), which was identical in size to 
that released from ricin A chain-treated ribosomes (Fig. 
2. lanes 6 and 8). 
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Fig. 4. Cytotoxicity of recombinant A chains to Vcro cells. Cells were 
plated out at 2 x lo5 cells/ml in 96-well plates and treated with ricin 
A chain (0). RCA A chain (a), ricin A chain which has been prein- 
cubated with IO-” M ticin B chain (0) or RCA A chain which had been 
prcincubated with IO-” M kin B chain (&. Cells were incubated for 
20 t? at 37°C. Each well was Ihcn pulsed tith 1 &i [‘)S]methionine 
for 2 h before determining the radioactivity incorporated into prolein. 
The incorporation observed was expressed as percentages relalcd to 
untreated control cells. 
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By scanning gels containing recombinant RCA A 
chain and comparing the intensity of the 30 kDa band 
with scans of gels containing known amounts of recom- 
binant ricin A chain, the quantity of RCA A chain in 
various preparations was determined. Inhibition of pro- 
tein synthesis in rabbit reticuiocyte !ysates was 
measured in the presence of either recombinant RCA A 
chain or recombinant ricin A chain (Fig. 3). The ICSo 
value (the concentration required for 50% inhibition of 
protein synthesis) for RCA A chain was estimated to be 
16.5 ndmi, 1 l-fold higher than that estimated for ricin 
A chain (1.5 @ml). 
Both recombinant RCA A chain and ricin A chain 
were capable of reassociating with purified ricin B chain 
to form cytotoxic heterodimers. Figure 4 indicates that 
preincubation of Vero ceils with either RCA A chain or 
ricin A chain over the concentration range indicated 
had no effect on protein biosynthetic capacity when 
compared to untreated ceils. When the A chains, at the 
concentrations indicated, were preincubated with lo-” 
M ricin B chain prior to incubation with Vero ceils, 
hoiotoxin which was cytotoxic at the higher A chain 
concentrations was generated. While holotoxin contain- 
ing ricin A chain appeared to be slightly more cytotoxic 
than that containing RCA A chain, both recombinant 
A chains were clearly trarrslocationaily competent and 
potently toxic in this whole ceil assay. 
In conclusion, RCA A chain has been produced cy- 
toplasmically in E. co/i in a soluble, stable and biologi- 
cally active form. RCA A chains have the ribosomai 
RNA r+giycosidase activity characteristic of ail plant 
ribosome inactivating proteins, although it was roughly 
one order to magnitude less active than ricin A chain 
under the assay conditions employed here, RCA A 
chain was capable of associating with purified ricin B 
chain to produce a molecule, presumably heterodi- 
merit, that was cytotoxic to Vero cells. While RCA 
A-ricin B conjugates appeared to be slightly less cyto- 
toxic than native ri-:in, the difference in cytotoxicity Gas 
markedly less than the 2,000-fold difference reported 
between tetrameric RCA and dimeric ricin [3]. This dif- 
ference in cytotoxicity observed with the purified lectins 
clearly does not simply reflect hb difference in biologi- 
cal activity of the respective A chains. Rather, it appears 
to be due to B chain-mediated difference in quaternary 
structure which in turn probably influences the case 
with which the A chains are delivered into the cytosol 
of target ceils. 
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